Aap Implantate AG
AAQ1
Rank in Stocks
#25992
Operating as a medical technology firm, aap Implantate AG specializes in the... Operating as a medical technology firm, aap Implantate AG specializes in the development, manufacturing, and commercialization of orthopedic trauma devices. The company's market presence spans Germany, the United States, and various international regions. Its primary offerings feature LOQTEQ, an advanced anatomical plating system crucial for fracture treatment, in addition to a diverse selection of cannulated screws, conventional plates, and standard screws. Products are distributed under the 'aap' brand, reaching customers directly, including hospitals, purchasing syndicates, and hospital groups, as well as indirectly via its network of distributors. aap Implantate AG was founded in 1990 and maintains its corporate headquarters in Berlin, Germany.
Share Price
$1.56
Last synced: 2026-11-11
Market Cap
$22.58M
Change (1 day)
0.95%
Change (1 year)
-7.35%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Aap Implantate AG (AAQ1)
Category
Healthcare
EPS for Aap Implantate AG (AAQ1)
EPS as of June 2026 TTM: $-0.21
According to Aap Implantate AG's latest financial reports, its current EPS (TTM) is $-0.21. At the end of 2025 the company had an EPS of $-0.22, an increase over its 2024 EPS of $-0.39.
EPS history for Aap Implantate AG from 2002 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.21 | -3.68% |
| 2025 | $-0.22 | -42.10% |
| 2024 | $-0.39 | -43.83% |
| 2023 | $-0.69 | 48.61% |
| 2022 | $-0.46 | -26.26% |
| 2021 | $-0.63 | -80.02% |
| 2020 | $-3.13 | -50.10% |
| 2019 | $-6.27 | 121.86% |
| 2018 | $-2.83 | -19.59% |
| 2017 | $-3.52 | 23.30% |
| 2016 | $-2.85 | 68.33% |
| 2015 | $-1.69 | 976.86% |
| 2014 | $-0.16 | -81.84% |
| 2013 | $-0.87 | -191.23% |
| 2012 | $0.95 | 511.53% |
| 2011 | $0.16 | 612.39% |
| 2010 | $0.02 | -97.59% |
| 2009 | $0.90 | -135.81% |
| 2008 | $-2.52 | -419.59% |
| 2007 | $0.79 | -25.94% |
| 2006 | $1.07 | 150.54% |
| 2005 | $0.43 | -309.14% |
| 2004 | $-0.20 | -99.39% |
| 2003 | $-33.45 | 304.99% |
| 2002 | $-8.26 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $8.45 | -4,087.73% |
IE
|
|
| $0.21 | -198.40% |
CN
|
|
| $19.69 | -9,391.55% |
CH
|
|
| $4.34 | -2,147.19% |
CH
|
|
| $0.13 | -159.46% |
CN
|
Questions about Aap Implantate AG's earnings per share (EPS)
What is Aap Implantate AG's earnings per share (EPS)?
Aap Implantate AG's earnings per share (EPS) over the last twelve months is $-0.21, as of Jun 2026.
What was Aap Implantate AG's earnings per share (EPS) in 2025?
In 2025, Aap Implantate AG's earnings per share (EPS) was $-0.22, compared with $-0.39 in 2024.
How has Aap Implantate AG's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Aap Implantate AG's earnings per share (EPS) was highest in 2025 ($-0.22) and lowest in 2020 ($-3.13).
How does Aap Implantate AG's earnings per share (EPS) compare with similar companies?
Aap Implantate AG's earnings per share (EPS) ($-0.21) is lower than that of all 5 similar companies listed above. The highest among them is Ypsomed Holding AG, with $19.69.